Estimating the cost of blood: past, present, and future directions
Tóm tắt
Từ khóa
Tài liệu tham khảo
Van Hulst, 2002, Pharmaco-economics of blood transfusion safety: review of the available evidence, Vox Sanguinis, 83, 146, 10.1046/j.1423-0410.2002.00198.x
Jackson, 2003, The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations, Transfusion, 43, 721, 10.1046/j.1537-2995.2003.00392.x
Vamvakas, 1996, Epidemiology of red blood cell utilization, Transfusion Medicine Reviews, 10, 44, 10.1016/S0887-7963(96)80122-2
Goodnough, 1999, Transfusion medicine. First of two parts: blood transfusion, The New England Journal of Medicine, 340, 438, 10.1056/NEJM199902113400606
Hannon, 2006, The contemporary economics of transfusions, 13
Sloand, 1995, Safety of the blood supply, JAMA: The Journal of the American Medical Association, 274, 1368, 10.1001/jama.274.17.1368
Brooks, 2005, Reengineering transfusion and cellular therapy processes hospitalwide: ensuring the safe utilization of blood products, Transfusion, 45, 159S, 10.1111/j.1537-2995.2005.00617.x
Blumberg, 1997, Allogeneic transfusion and infection: economic and clinical implications, Seminars in Hematology, 34, 34
Williamson, 1999, Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports, British Medical Journal, 319, 16, 10.1136/bmj.319.7201.16
Sazama, 2000, Practice parameter for the recognition, management, and prevention of adverse consequences of blood transfusion, Archives of Pathology & Laboratory Medicine, 124, 61, 10.5858/2000-124-0061-PPFTRM
Perrotta, 2001, Non-infectious complications of transfusion therapy, Blood Reviews, 15, 69, 10.1054/blre.2001.0151
Klein, 1995, Allogeneic transfusion risks in the surgical patient, American Journal of Surgery, 170, 21S, 10.1016/S0002-9610(99)80054-3
Dodd, 1994, Adverse consequences of blood transfusion: quantitative risk estimates, 1
Kopko, 2002, Transfusion-related acute lung injury: report of a clinical look-back investigation, JAMA: The Journal of the American Medical Association, 287, 1968, 10.1001/jama.287.15.1968
Denton, 1994, Anemia therapy: individual benefit and societal cost, Seminars in Oncology, 21, 29
Barnett, 2002, Anemia-related costs for cancer patients, Journal of Managed Care Medicne, 6, 20
Levy, 2005, A descriptive evaluation of transfusion practices in patients receiving mechanical ventilation, Chest, 27, 928, 10.1378/chest.127.3.928
Rosencher, 2003, Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe, Transfusion, 43, 459, 10.1046/j.1537-2995.2003.00348.x
Hébert, 1999, Variation in red cell transfusion practice in the intensive care unit: a multicentre cohort study, Critical care (London, England), 3, 57, 10.1186/cc310
Capraro, 2000, Transfusion thresholds in common elective surgical procedures in Finland, Vox Sanguinis, 78, 96, 10.1046/j.1423-0410.2000.7820096.x
Goodnough, 1993, Economic impact of inappropriate blood transfusions in coronary artery bypass graft surgery, The American Journal of Medicine, 94, 509, 10.1016/0002-9343(93)90086-5
Vincent, 2002, Anemia and blood transfusion in critically ill patients, JAMA: The Journal of the American Medical Association, 288, 1499, 10.1001/jama.288.12.1499
Dunne, 2002, Perioperative anemia: an independent risk factor for infection, mortality, and resource utilization in surgery, The Journal of Surgical Research, 102, 237, 10.1006/jsre.2001.6330
Taylor, 2006, Red blood cell transfusions and nosocomial infections in critically ill patients, Critical Care Medicine, 34, 2302, 10.1097/01.CCM.0000234034.51040.7F
Zallen, 1999, Age of transfused blood is an independent risk factor for postinjury multiple organ failure, American Journal of Surgery, 178, 570, 10.1016/S0002-9610(99)00239-1
Moore, 1997, Blood transfusion. An independent risk factor for postinjury multiple organ failure, Archives of Surgery, 132, 620, 10.1001/archsurg.1997.01430300062013
Corwin, 2004, The CRIT study: anemia and blood transfusion in the critically ill – current clinical practice in the United States, Critical Care Medicine, 32, 39, 10.1097/01.CCM.0000104112.34142.79
Vamvakas, 1998, Allogeneic blood transfusion, hospital charges, and length of hospitalization: a study of 487 consecutive patients undergoing colorectal cancer resection, Archives of Pathology & Laboratory Medicine, 122, 145
Forbes, 1991, Blood transfusion costs: a multicenter study, Transfusion, 31, 318, 10.1046/j.1537-2995.1991.31491213295.x
Mohandas, 1995, Transfusion requirements, risks, and costs for patients with malignancy, Transfusion, 35, 427, 10.1046/j.1537-2995.1995.35595259154.x
Cantor, 1998, Costs of blood transfusion: a process-flow analysis, Journal of Clinical Oncology, 16, 2364, 10.1200/JCO.1998.16.7.2364
Crémieux, 2000, Cost of outpatient blood transfusion in cancer patients, Journal of Clinical Oncology, 18, 2755, 10.1200/JCO.2000.18.14.2755
Jackson, 2000, The cost-effectiveness of postoperative recovery of RBCs in preventing transfusion-associated virus transmission after joint arthroplasty, Transfusion, 40, 1063, 10.1046/j.1537-2995.2000.40091063.x
Fergusson, 2002, Effectiveness of WBC reduction in neonates: what is the evidence of benefit?, Transfusion, 42, 159, 10.1046/j.1537-2995.2002.00022.x
Wayne, 2000, Financial analysis of chronic transfusion for stroke prevention in sickle cell disease, Blood, 96, 2369, 10.1182/blood.V96.7.2369
Grimm, 1989, Economics of epoetin therapy, Clinical Pharmacy, 8, 807
Sheingold, 1991, Recombinant human erythropoietin: factors to consider in cost-benefit analysis, American Journal of Kidney Diseases, 17, 86, 10.1016/S0272-6386(12)80258-7
Sheffield, 1997, Cost comparison of recombinant human erythropoietin and blood transfusion in cancer chemotherapy-induced anemia, The Annals of Pharmacotherapy, 31, 15, 10.1177/106002809703100101
Kavanagh, 2001, Cost analysis of erythropoietin versus blood transfusions for cervical cancer patients receiving chemoradiotherapy, International Journal of Radiation Oncology, Biology, Physics, 51, 435, 10.1016/S0360-3016(01)01645-5
Etchason, 1995, The cost effectiveness of preoperative autologous blood donations, The New England Journal of Medicine, 332, 719, 10.1056/NEJM199503163321106
Keating, 1998, Predictors of transfusion risk in elective knee surgery, Clinical Orthopaedics, 357, 50, 10.1097/00003086-199812000-00008
Shander, 2005, The cost of blood: multidisciplinary consensus conference for a standard methodology, Transfusion Medicine Reviews, 19, 66, 10.1016/j.tmrv.2004.09.005
Goodman, 2003, Ensuring blood safety and availability in the US: technological advances, costs, and challenges to payment–final report, Transfusion, 43, 3S, 10.1046/j.1537-2995.43.8s.2.x
Wallace, 1998, Collection and transfusion of blood and blood components in the United States, 1994, Transfusion, 38, 625, 10.1046/j.1537-2995.1998.38798346630.x
Brand, 2000, Immunological aspects of blood transfusions, Blood Reviews, 14, 130, 10.1054/blre.2000.0131
Bordin, 1994, Biologic effects of leukocytes present in transfused cellular blood products, Blood, 84, 1703, 10.1182/blood.V84.6.1703.1703
Pittman, 2000, Rationale for universal WBC reduction of blood components?, Transfusion, 40, 389, 10.1046/j.1537-2995.2000.40030389.x
Dzik, 2000, Leukocyte reduction of blood components: public policy and new technology, Transfusion Medicine Reviews, 14, 34, 10.1016/S0887-7963(00)80114-5
Birkmeyer, 1993, The cost-effectiveness of preoperative autologous blood donation for total hip and knee replacement, Transfusion, 33, 544, 10.1046/j.1537-2995.1993.33793325048.x
Combs, 1992, Cost-benefit analysis of autologous blood donation in obstetrics, Obstetrics and Gynecology, 80, 621
Goodnough, 1994, Blood transfusion and blood conservation: cost and utilization issues, American Journal of Medical Quality, 9, 172, 10.1177/0885713X9400900408
Duffy, 1997, Cost analysis of autologous blood transfusion, using cell salvage, compared with allogeneic blood transfusion, Transfusion Medicine (Oxford, England), 7, 189, 10.1046/j.1365-3148.1997.d01-25.x
Blumberg, 1996, Immunomodulation by blood transfusion: an evolving scientific and clinical challenge, The American Journal of Medicine, 101, 299, 10.1016/S0002-9343(96)00124-6
Roddie, 2000, Leucocyte depletion of blood components, Blood Reviews, 14, 145, 10.1054/blre.2000.0130
van de Watering, 1998, Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial, Circulation, 97, 562, 10.1161/01.CIR.97.6.562
van de Watering, 2001, Perioperative blood transfusions, with or without allogeneic leucocytes, relate to survival, not to cancer recurrence, The British Journal of Surgery, 88, 267, 10.1046/j.1365-2168.2001.01674.x
Pruss, 2004, Universal leukodepletion of blood components results in a significant reduction of febrile non-hemolytic but not allergic transfusion reactions, Transfusion and Apheresis Science, 30, 41, 10.1016/j.transci.2003.08.013
Fisk, 2005, Universal pre-storage leukoreduction – a defensible use of hospital resources: the Yale-New Haven Hospital experience, Developmental Biology, 120, 39
Houbiers, 1994, Leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer, Lancet, 344, 1429, 10.1016/S0140-6736(94)91965-8
Vamvakas, 2000, The cost-effectiveness of autologous transfusion revisited: implications of an increased risk of bacterial infection with allogeneic transfusion, Transfusion, 40, 384, 10.1046/j.1537-2995.2000.40030384.x
Jensen, 1995, Cost-effectiveness of blood transfusion and white cell reduction in elective colorectal surgery, Transfusion, 35, 719, 10.1046/j.1537-2995.1995.35996029153.x
Blumberg, 1995, Leukodepleted-ABO-identical blood components in the treatment of hematologic malignancies: a cost analysis, American Journal of Hematology, 48, 108, 10.1002/ajh.2830480208
Purdy, 1997, Association of mortality with age of blood transfused in septic ICU patients, Canadian Journal of Anaesthesia, 44, 1256, 10.1007/BF03012772
Mynster, 1999, Prestorage leukofiltration of whole blood and SAGM blood prevents extracellular bioactive substance accumulation, Inflammation Research, 48, 363, 10.1007/s000110050473
Marik, 1993, Effect of stored-blood transfusion on oxygen delivery in patients with sepsis, JAMA: The Journal of the American Medical Association, 269, 3024, 10.1001/jama.269.23.3024
Offner, 2002, Increased rate of infection associated with transfusion of old blood after severe injury, Archives of Surgery, 137, 711, 10.1001/archsurg.137.6.711
Vamvakas, 1999, Transfusion and postoperative pneumonia in coronary artery bypass graft surgery: effect of the length of storage of transfused red cells, Transfusion, 39, 701, 10.1046/j.1537-2995.1999.39070701.x
National Blood Data Resource Center
Perkins, 2000, Should the FDA mandate that autologous units drawn and transfused within a single institution be tested for markers of infectious disease?, Transfusion, 40, 752, 10.1046/j.1537-2995.2000.40060752.x
NIH Consensus Development Panel on Infectious Disease Testing for Blood Transfusions, 1995, Infectious disease testing for blood transfusions, JAMA: The Journal of the American Medical Association, 274, 1374, 10.1001/jama.274.17.1374
Food and Drug Administration, 2001, Requirements for testing human blood donors for evidence of infection due to communicable disease agents. Final rule, Federal Register, 66, 31146
Margolis, 1995, Prevention of hepatitis B virus transmission by immunization: an economic analysis of current recommendations, JAMA: The Journal of the American Medical Association, 274, 1201, 10.1001/jama.274.15.1201
Busch, 2000, NAT and blood safety: what is the paradigm?, Transfusion, 40, 1157, 10.1046/j.1537-2995.2000.40101157.x
Reesink, 1998, Consequences of nucleic acid amplification testing for blood transfusion centres, Vox Sanguinis, 74, 263, 10.1046/j.1423-0410.1998.74402631.x
Legler, 2000, Testing of individual blood donations for HCV RNA reduces the residual risk of transfusion-transmitted HCV infection, Transfusion, 40, 1192, 10.1046/j.1537-2995.2000.40101192.x
Stramer, 2000, NAT of the United States and Canadian blood supply, Transfusion, 40, 1165, 10.1046/j.1537-2995.2000.40101165.x
AuBuchon, 1997, Cost-effectiveness of expanded human immunodeficiency virus-testing protocols for donated blood, Transfusion, 37, 45, 10.1046/j.1537-2995.1997.37197176950.x
Jackson, 2000, Cost-effectiveness of nucleic acid testing for HIV and HCV in donated blood, Transfusion, 40, 1385
Pelletier, 2006, Pathogen inactivation techniques, Best Practice & Research. Clinical Haematology, 19, 205, 10.1016/j.beha.2005.04.001
AuBuchon, 2002, Production of pathogen-inactivated RBC concentrates using PEN110 chemistry: a Phase I clinical study, Transfusion, 42, 146, 10.1046/j.1537-2995.2002.00021.x
Hambleton, 2002, RBCs treated with Helinx™ pathogen inactivation have recovery and half-life comparable to conventional RBCs in a randomized crossover trial
Laupacis, 1998, Erythropoietin to minimize perioperative blood transfusion: a systematic review of randomized trials. The International Study of Peri-operative Transfusion (ISPOT) Investigators, Transfusion Medicine (Oxford, England), 8, 309, 10.1046/j.1365-3148.1998.00171.x
Titlestad, 2002, Monitoring transfusion practice - a computerized procedure, Transfusion Medicine (Oxford, England), 12, 25, 10.1046/j.1365-3148.2002.00352.x
Jensen, 1996, An automated system for bedside verification of the match between patient identification and blood unit identification, Transfusion, 36, 216, 10.1046/j.1537-2995.1996.36396182138.x
Sherwood, 1994, The use of computers in the blood bank to reduce transfusion risk, 25
AuBuchon, 1996, A cost-effectiveness analysis of the use of a mechanical barrier system to reduce the risk of mistransfusion, Transfusion, 36, 222, 10.1046/j.1537-2995.1996.36396182139.x
Sazama, 1996, Current good manufacturing practices for transfusion medicine, Transfusion Medicine Reviews, X, 286, 10.1016/S0887-7963(96)80004-6
Callum, 2000, An evaluation of the process and costs associated with targeted lookbacks for HCV and general notification of transfusion recipients, Transfusion, 40, 1169, 10.1046/j.1537-2995.2000.40101169.x
McCarthy, 1993, Who should be screened for HIV infection? A cost-effectiveness analysis, Archives of Internal Medicine, 153, 1107, 10.1001/archinte.153.9.1107
Hellinger, 1993, The lifetime cost of treating a person with HIV, JAMA: The Journal of the American Medical Association, 270, 474, 10.1001/jama.270.4.474
Sonnenberg, 1999, The cost-effectiveness of autologous transfusion revisited: implications of an increased risk of bacterial infection with allogeneic transfusion, Transfusion, 39, 808, 10.1046/j.1537-2995.1999.39080808.x
Wong, 1995, Cost-effectiveness of interferon-α2b treatment for hepatitis B e antigen-positive chronic hepatitis B, Annals of Internal Medicine, 122, 664, 10.7326/0003-4819-122-9-199505010-00004
Carson, 1999, Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair, Transfusion, 39, 694, 10.1046/j.1537-2995.1999.39070694.x
Dickie, 1998, Relationship between TISS and ICU cost, Intensive Care Medicine, 24, 1009, 10.1007/s001340050709
Schreiber, 1996, The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study, The New England Journal of Medicine, 334, 1685, 10.1056/NEJM199606273342601
Sazama, 1990, Reports of 355 transfusion-associated deaths: 1976 through 1985, Transfusion, 30, 583, 10.1046/j.1537-2995.1990.30790385515.x
Sazama, 1994, Bacteria in blood for transfusion: a review, Archives of Pathology & Laboratory Medicine, 118, 350
Papia, 1999, Infection in hospitalized trauma patients: incidence, risk factors, and complications, The Journal of Trauma, 47, 923, 10.1097/00005373-199911000-00018
Vrielink, 1998, Transfusion-transmissible infections, Current Opinion in Hematology, 5, 396, 10.1097/00062752-199811000-00008
Fransen, 1999, Impact of blood transfusions on inflammatory mediator release in patients undergoing cardiac surgery, Chest, 116, 1233, 10.1378/chest.116.5.1233
Claas, 2001, Modulation of the alloimmune response by blood transfusions, Transfusion Clinique et Biologique, 8, 315, 10.1016/S1246-7820(01)00122-7
Hull, 1995, Transfusion-associated chronic cutaneous graft-versus-host disease, Journal of the American Academy of Dermatology, 33, 327, 10.1016/0190-9622(95)91427-7
Silliman, 1999, Transfusion-related acute lung injury, Transfusion Medicine Reviews, 13, 177, 10.1016/S0887-7963(99)80031-5
Hebert, 2001, Disclosure of adverse events and errors in healthcare: an ethical perspective, Drug Safety, 24, 1095, 10.2165/00002018-200124150-00001
Liu, 2002, Nosocomial blood-stream infection in patients with end-stage renal disease: excess length of hospital stay, extra cost and attributable mortality, The Journal of Hospital Infection, 50, 224, 10.1053/jhin.2001.1162
Orsi, 2002, Hospital-acquired, laboratory-confirmed bloodstream infection: increased hospital stay and direct costs, Infection Control and Hospital Epidemiology, 23, 190, 10.1086/502034
Letarte, 2002, Patient characteristics and costs of severe sepsis and septic shock in Quebec, Journal of Critical Care, 17, 39, 10.1053/jcrc.2002.33028
Angus, 2001, Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care, Critical Care Medicine, 29, 1303, 10.1097/00003246-200107000-00002
Sazama, 1994, Legal aspects of transfusion medicine, MLO: Medical Laboratory Observer, 26, 33
Sullivan, 2005, Developing an administrative plan for transfusion medicine–a global perspective, Transfusion, 45, 224S, 10.1111/j.1537-2995.2005.00621.x
Asadi, 1996, Activity-based costing for clinical paths. An example to improve clinical cost & efficiency, Journal of the Society for Health Systems, 5, 1
Shander A, Goodnough LT. Objectives and limitations of bloodless medical care. Current Opinion in Hematology 2006; 13:462–470.
Monk, 1995, Acute normovolemic hemodilution is a cost-effective alternative to preoperative autologous blood donation by patients undergoing radical retropubic prostatectomy, Transfusion, 35, 559, 10.1046/j.1537-2995.1995.35795357877.x
Pereira, 2000, Cost-effectiveness analysis and the selection of blood products, Current Opinion in Hematology, 7, 420, 10.1097/00062752-200011000-00017
Chernow, 1993, Blood conservation in critical care–the evidence accumulates, Critical Care Medicine, 21, 481, 10.1097/00003246-199304000-00001
Goodnough, 1995, The relationship between hematocrit, blood lost, and blood transfused in total knee replacement. Implications for postoperative blood salvage and reinfusion, The American Journal of Knee Surgery, 8, 83
Keating, 2002, Transfusion options in total joint arthroplasty, The Journal of Arthroplasty, 17, 125, 10.1054/arth.2002.32459
Littlewood, 2001, Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial, Journal of Clinical Oncology, 19, 2865, 10.1200/JCO.2001.19.11.2865
Crawford, 2002, Clinical benefits of epoetin alfa therapy in patients with lung cancer, Clinical Lung Cancer, 3, 180, 10.3816/CLC.2002.n.001
Demetri, 1998, Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study, Journal of Clinical Oncology, 16, 3412, 10.1200/JCO.1998.16.10.3412
Gabrilove, 1999, Once-weekly dosing of epoetin-alfa is similar to three-times-weekly dosing in increasing hemoglobin and quality of life, Proceedings American Society of Clinical Oncology, 18, 574a
Glaspy, 2002, Comparable efficacy of epoetin alfa for anemic cancer patients receiving platinum- and nonplatinum-based chemotherapy: a retrospective subanalysis of two large, community-based trials, Oncologist, 7, 126, 10.1634/theoncologist.7-2-126
Frankenfield, 2002, Current management of anemia in adult hemodialysis patients with end-stage renal disease, American Journal of Health-system Pharmacy, 59, 429, 10.1093/ajhp/59.5.429